Pulmonary Embolism Response Teams: A Novel Approach for the Care of Complex Patients With Pulmonary Embolism.
Mateo Porres-AguilarJavier E Anaya-AyalaGustavo A HeresiBelinda N Rivera-LebronPublished in: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis (2018)
Pulmonary embolism represents the third most common cause of cardiovascular death in the United States. Reperfusion therapeutic strategies such as systemic thrombolysis, catheter directed therapies, surgical pulmonary embolectomy, and cardiopulmonary support devices are currently available for patients with high- and intermediate-high-risk pulmonary embolism. However, deciding on optimal therapy may be challenging. Pulmonary embolism response teams have been designed to facilitate multidisciplinary decision-making with the goal to improve quality of care for complex cases with pulmonary embolism. Herein, we discuss the current role and strategies on how to leverage the strengths from pulmonary embolism response teams, its possible worldwide adoption, and implementation to improve survival and change the paradigm in the care of a potentially deadly disease.
Keyphrases
- pulmonary embolism
- inferior vena cava
- quality improvement
- healthcare
- palliative care
- primary care
- pulmonary hypertension
- stem cells
- acute myocardial infarction
- heart failure
- mesenchymal stem cells
- coronary artery disease
- chronic pain
- subarachnoid hemorrhage
- percutaneous coronary intervention
- cerebral ischemia
- ultrasound guided